Bhatnagar Anish $SLNO SEC Form 4 Insider Trading

Bhatnagar Anish has filed a total of 41 insider trades in $SLNO since 2021. Their most recent trade was a sale of 732 shares, made on Mar 27, 2025. Their largest trade was a sale of 209,689 shares, made on Mar 27, 2025. We estimate that they now own 577,076 shares of $SLNO, worth an estimated $43.2 million.

Insider Trading at $SLNO

There have been a total of 301 insider trades reported at $SLNO since 2021, with 22.6 million shares purchased and 8.7 million shares sold. The most active insider traders in $SLNO stock have been Patricia C Hirano, Bhatnagar Anish, and James H Mackaness. The most recent trade was a sale of 3,782 shares reported by Patricia C Hirano (SEE REMARKS), made on Apr 01, 2025.

$SLNO Executives and Stock Owners with Insider Trades

• Patricia C Hirano, SEE REMARKS

• Bhatnagar Anish, CHIEF EXECUTIVE OFFICER

• James H Mackaness, CHIEF FINANCIAL OFFICER

• Kristen Yen, SEE REMARKS

• James H Mackaness, Chief Financial Officer

• Bhatnagar Anish, Chief Executive Officer

• Meredith Manning, Chief Commercial Officer

• Michael F. Huang, Sr. VP of Clinical Development

• Kristen Yen, See Remarks

• Patricia C Hirano, See Remarks

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.